Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antipsychotic agents AND hospital admission AND psychiatric hospital AND schizophrenia:

Search results

Items: 1 to 20 of 239

1.

C-reactive protein levels and treatment resistance in schizophrenia-A Danish population-based cohort study.

Horsdal HT, Wimberley T, Benros ME, Gasse C.

Hum Psychopharmacol. 2017 Nov;32(6). doi: 10.1002/hup.2632. Epub 2017 Sep 26.

PMID:
28952165
2.

Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.

Ohi K, Kuwata A, Shimada T, Yasuyama T, Nitta Y, Uehara T, Kawasaki Y.

Medicine (Baltimore). 2017 Apr;96(16):e6566. doi: 10.1097/MD.0000000000006566.

3.

Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.

Lopez LV, Shaikh A, Merson J, Greenberg J, Suckow RF, Kane JM.

J Clin Psychopharmacol. 2017 Jun;37(3):310-314. doi: 10.1097/JCP.0000000000000697.

PMID:
28353490
4.

One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.

Vincent PD, Demers MF, Doyon-Kemp V, Duchesneau J, Halme A, Masson V.

Schizophr Res. 2017 Jul;185:96-100. doi: 10.1016/j.schres.2017.01.013. Epub 2017 Jan 22.

PMID:
28119036
5.

Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia.

Ifteni P, Szalontay AS, Teodorescu A.

Am J Ther. 2017 Mar/Apr;24(2):e222-e226. doi: 10.1097/MJT.0000000000000533.

PMID:
27984264
6.

Haloperidol for long-term aggression in psychosis.

Khushu A, Powney MJ.

Cochrane Database Syst Rev. 2016 Nov 27;11:CD009830. Review.

PMID:
27889922
7.

Antipsychotic Medications and Risk of Acute Coronary Syndrome in Schizophrenia: A Nested Case-Control Study.

Liu HC, Yang SY, Liao YT, Chen CC, Kuo CJ.

PLoS One. 2016 Sep 22;11(9):e0163533. doi: 10.1371/journal.pone.0163533. eCollection 2016.

8.

-759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.

Daray FM, Rodante D, Carosella LG, Silva ME, Martínez M, Fernández Busch MV, Faccone DF, Rothlin RP, Maffía PC.

Pharmacopsychiatry. 2017 Jan;50(1):14-18. doi: 10.1055/s-0042-110321. Epub 2016 Jul 14.

PMID:
27414739
9.

Inverse association between urbanicity and treatment resistance in schizophrenia.

Wimberley T, Pedersen CB, MacCabe JH, Støvring H, Astrup A, Sørensen HJ, Horsdal HT, Mortensen PB, Gasse C.

Schizophr Res. 2016 Jul;174(1-3):150-155. doi: 10.1016/j.schres.2016.03.021. Epub 2016 Apr 8.

PMID:
27066856
10.

Efficacy of Long-Acting Injectable Antipsychotics in Adolescents.

Pope S, Zaraa SG.

J Child Adolesc Psychopharmacol. 2016 May;26(4):391-4. doi: 10.1089/cap.2015.0091. Epub 2016 Mar 30.

PMID:
27028966
11.

Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study.

Wimberley T, Støvring H, Sørensen HJ, Horsdal HT, MacCabe JH, Gasse C.

Lancet Psychiatry. 2016 Apr;3(4):358-66. doi: 10.1016/S2215-0366(15)00575-1. Epub 2016 Feb 25. Erratum in: Lancet Psychiatry. 2016 Apr;3(4):320.

PMID:
26922475
12.

'As required' medication regimens for seriously mentally ill people in hospital.

Douglas-Hall P, Whicher EV.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD003441. doi: 10.1002/14651858.CD003441.pub3. Review.

PMID:
26689942
13.

Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.

Stroup TS, Gerhard T, Crystal S, Huang C, Olfson M.

Am J Psychiatry. 2016 Feb 1;173(2):166-73. doi: 10.1176/appi.ajp.2015.15030332. Epub 2015 Nov 6.

PMID:
26541815
14.

Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.

Chen VC, Liao YT, Lai TJ, Lane HY, Shao WC, Dewey M, Lee CT, Lu ML.

Schizophr Res. 2015 Dec;169(1-3):406-411. doi: 10.1016/j.schres.2015.10.005. Epub 2015 Oct 23.

PMID:
26481616
15.

A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia--A nationwide study.

Yu HY, Hsiao CY, Chen KC, Lee LT, Chang WH, Chi MH, Hui Lee I, Chen PS, Yang YK.

Schizophr Res. 2015 Dec;169(1-3):400-405. doi: 10.1016/j.schres.2015.09.006. Epub 2015 Sep 26.

PMID:
26395153
16.

Risk factors for sudden cardiac death among patients with schizophrenia.

Hou PY, Hung GC, Jhong JR, Tsai SY, Chen CC, Kuo CJ.

Schizophr Res. 2015 Oct;168(1-2):395-401. doi: 10.1016/j.schres.2015.07.015. Epub 2015 Jul 22.

PMID:
26210551
17.

Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder.

Patel R, Shetty H, Jackson R, Broadbent M, Stewart R, Boydell J, McGuire P, Taylor M.

PLoS One. 2015 May 20;10(5):e0126530. doi: 10.1371/journal.pone.0126530. eCollection 2015.

18.

Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid.

Thomas KL, Jiang Y, McCombs JS.

Ann Clin Psychiatry. 2015 May;27(2):90-9.

PMID:
25696785
19.

Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.

Wu YH, Lai CY, Chang YS.

Psychogeriatrics. 2015 Mar;15(1):7-13. doi: 10.1111/psyg.12067. Epub 2014 Dec 17.

20.

[Theory and practice of pharmacological treatment of acute schizophrenia: a retrospective study].

Potanin SS, Burminskiĭ DS, Morozova MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(5):17-21. Russian.

PMID:
24988953

Supplemental Content

Loading ...
Support Center